Das Zentrum
Multiple Sklerose Zentrum Dresden
Patienteninformation
Kontaktinformation
Behandlungsteam
Studienteam
Neuropsychologie
Mobilitätszentrum
Das Mobilitätszentrum
Ganganalyse
Sprunganalyse
DIERS
EMIQ
Forschungsprojekte
Neuroimmunologisches Labor
Das NIL
Neurofilament-Leichtketten Analyse
Autonomes & Neuroendokrinologisches Funktionslabor
Das ANF
Untersuchungsmethoden
MS Living Lab
Management & Science
Team Management & Science
Projekte
eHealth & Analytics
MSDS 3D
MSDS Klinik & Praxis
MS-HRS
MTRS
MS Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
MS Tag 2025
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Spenden
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Digitalkalender 2026
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
Deutsch
Deutsch
English
Therapeutic decisions in multiple sclerosis moving beyond efficacy
Multiple Sclerosis
Jahr
Publikationsjahr
2013
Autoren
Autorenliste der Publikation
Brück W, Gold R, Lund BT, Oreja-Guevara C, Prat A, Spencer CM, Steinman L, Tintoré M, Vollmer TL, Weber MS, Weiner LP, Ziemssen T, Zamvil SS.
Verlag
Publisher-Information
JAMA Neurol. 2013 Oct;70(10):1315-24.
Link
Zur Publikation (externer Server)
https://doi.org/10.1001/jamaneurol.2013.3510
Tags
Forschungsthemen
Multiple Sklerose
MSZ
2013
Embodied conversational agents for collecting patient-reported data: effective for some, challenging for others – results of a cross-sectional study in multiple sclerosis care
MASC
Jahr
2026
Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world study
NIL
Jahr
2026
AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research
MASC
Jahr
2026
MS360°: a conceptual digital-first, data-driven hybrid care framework for personalised multiple sclerosis management
MASC
Jahr
2026
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews
Multiple Sclerosis
Jahr
2026
